CDKL3 and esophageal squamous cell carcinoma: Analysis of 24 samples from ESCC patients receiving nCRT found that low pre-treatment CDKL3 expression was positively related to pCR (pT-N-) (Figure 7A), pT- (Figure 7B), and pN- (Figure 7C) (p<0.01).